Actively Recruiting
Improving Colonoscopy Surveillance for Patients With High Risk Colon Polyps
Led by Jonsson Comprehensive Cancer Center · Updated on 2025-11-14
1680
Participants Needed
1
Research Sites
211 weeks
Total Duration
On this page
Sponsors
J
Jonsson Comprehensive Cancer Center
Lead Sponsor
N
National Cancer Institute (NCI)
Collaborating Sponsor
AI-Summary
What this Trial Is About
This clinical trial tests a multilevel intervention at the clinic, provider and patient levels, to improve colonoscopy surveillance in patients with high risk colon polyps. Colorectal cancer (CRC) is a common and deadly disease that is largely preventable through the detection and removal of colorectal polyps. One million Americans are diagnosed with high risk polyps of the colon or rectum annually and are at increased risk for CRC; however, uptake of recommended repeat colonoscopy in 3 years to reduce CRC risk is low in this group. This multilevel intervention may work to improve timely colonoscopy screening for patients with high risk colon polyps.
CONDITIONS
Official Title
Improving Colonoscopy Surveillance for Patients With High Risk Colon Polyps
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Patients aged between 45 and 75 years with a high risk neoplasia diagnosis in the past 5 years
- Patients who have had or have not had surveillance colonoscopy
- Primary care providers and gastroenterologists involved in patient care
- Administrators involved in colorectal cancer screening and colonoscopy scheduling
- Patients diagnosed with high risk neoplasia during the specified two-year diagnosis period
You will not qualify if you...
- Individuals with a personal history of colorectal carcinoma
- Individuals with inflammatory bowel disease such as Crohn's disease or ulcerative colitis
- Individuals with polyposis syndrome
- Cases of high risk neoplasia not confirmed by chart review
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
UCLA / Jonsson Comprehensive Cancer Center
Los Angeles, California, United States, 90095
Actively Recruiting
Research Team
J
Jenna Alarcon
CONTACT
How is the study designed?
Study Type
INTERVENTIONAL
Masking
NONE
Allocation
RANDOMIZED
Model
PARALLEL
Primary Purpose
SCREENING
Number of Arms
2
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here